BioSyent Inc. (RX:TSXV) closed at $17.70 on November 6, 2026, up 2.08% on the day. The stock trades 0.3% below its 52-week high of $17.75 and 66.2% above its 52-week low of $10.65. Over the past year, it gained 61.3%. BioSyent Inc. is part of the Life Sciences sector (Pharmaceuticals).
In 252 trading sessions since November 6, 2025, RX closed higher on 120 days (48%). Its best day was February 4, 2026 (+11.55%) and its worst was February 6, 2026 (-7.25%). The stock moved 10% or more in a single session 1 time.
Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include Proktis, Cathajell Jelly, and among others.
Find more stocks like RX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.